-
Signature
-
/s/ Alexandre Weinstein Manieu
-
Issuer symbol
-
PLUR
-
Transactions as of
-
29 Oct 2025
-
Net transactions value
-
+$2,087,056
-
Form type
-
4
-
Filing time
-
20 Nov 2025, 11:35:50 UTC
Reporting Owners (2)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Manieu Alexandre Weinstein |
Director, 10%+ Owner |
APT 8002, BURGENSTOCK HOTELS & RESORT,, BURGENSTOCK 30, OBBURGEN, SWITZERLAND |
/s/ Alexandre Weinstein Manieu |
20 Nov 2025 |
0001833124 |
| Chutzpah Holdings Ltd |
Director, 10%+ Owner |
4TH FLOOR, LIBERATION HOUSE, CASTLE STREET, ST. HELIER, JERSEY |
/s/ Ana Ventura Authorized Officer For Beaumont (Directors) Limited Sole Corporate Director |
20 Nov 2025 |
0002055515 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
PLUR |
Common Stock |
Award |
$0 |
+10,250 |
|
$0.000000 |
10,250 |
25 Feb 2025 |
Direct |
|
| transaction |
PLUR |
Common Stock |
Options Exercise |
$100 |
+1,002,169 |
+108% |
$0.000100 |
1,933,415 |
29 Oct 2025 |
Shares indirectly held through Chutzpah Holdings Limited |
F1, F3 |
| transaction |
PLUR |
Common Stock |
Purchase |
$2,086,956 |
+452,702 |
|
$4.61 |
452,702 |
28 Apr 2025 |
Shares indirectly held through Plantae Bioscience Ltd. |
F2 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
PLUR |
Pre-Funded Warrants to purchase Common Shares |
Options Exercise |
$0 |
-1,002,169 |
-92% |
$0.000000 |
84,599 |
29 Oct 2025 |
Common Shares |
0 |
$0.000100 |
Indirectly held through Chutzpah Holdings Limited |
F1, F3, F4, F5, F7 |
| transaction |
PLUR |
Common Warrants |
Award |
$0 |
+84,599 |
|
$0.000000 |
84,599 |
23 Jan 2025 |
Common Shares |
0 |
$5.57 |
Indirectly held through Chutzpah Holdings Limited |
F1, F4, F6, F7 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
Remarks:
Exhibit Index: Exhibit 99.1 - Joint Filer Information (incorporated by reference to Exhibit 99.1 for Form 3 filed with the Securities and Exchange Commission on February 18, 2025). Exhibit 99.2 - Joint Filing Agreement (incorporated by reference to Exhibit 99.2 for Form 3 filed with the Securities and Exchange Commission on February 18, 2025). Each reporting person states that neither the filing of this statement nor anything herein shall be deemed an admission that such person is, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise, the beneficial owner of any securities covered by this statement. Each reporting person disclaims beneficial ownership of the securities covered by this statement, except to the extent of the pecuniary interest of such person in such securities. Each reporting person declares that neither the filing of this statement nor anything herein shall be construed as an admission that such person is, for the purposes of Section 13(d) or13(g) of the Act or any other purpose, a member of a group with respect to the issuer or securities of the issuer.